Skip to content

Endocrine Glucose & Lipids Metabolism and Brain Aging: a Longitudinal Study

A Prospective Cohort Study on the Associations of Endocrine Glucose & Lipids With Brain Aging-related Conditions in Chinese Men and Women

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06066775
Enrollment
10000
Registered
2023-10-04
Start date
2023-07-04
Completion date
2033-12-31
Last updated
2023-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Aging Related Conditions

Keywords

brain aging, cognition, lipid, glucose

Brief summary

With aging, brain aging leads to a general decline in cognitive ability, and the prevalence of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) increases. The prevalence of abnormal glucose and lipid metabolism also increased with age. The imbalance of glucose and lipid metabolism is closely related to brain aging related conditions and diseases, and the relationship between glucose and lipid metabolism and brain aging has not been fully elucidated. Phase 1: Baseline investigation (community-based survey) Aims: To investigate whether glucose and lipids are the risk factors for brain aging-related conditions, such as mild cognitive impairment. Subjects and Methods: A community-based survey will be carried out in 10000 natural population aged \>=50 years selected from 10-12 communities stratified according to geographic regions (Ciyao, Huafeng, Dongzhuang, Heshan, Geshi, Jiangji, Gangcheng, Fushan, Dongshu, Sidian, Baxianqiao, and Xiangyin, etc) in Ningyang County, Taian City, Shandong Province. A comprehensive examination including questionnaire (including the MMSE and ADL evaluation for the participants), anthropometric measurements, biochemical analysis will be performed in each study participant. In particular, the investigators randomly selected 1000-2000 participants performing MRI of the brain to evaluate the brain aging related conditions. Phase 2: Cohort follow-up Aims : To examine glucose and lipids metabolism levels and their changes that modify the risk of brain aging-related conditions. Subjects and Methods: To recruit and follow all 10000 participants for at least 3-5 years. In particular, all 1000-2000 participants with the baseline MRI examination will perform the MRI examination again for the follow-up.

Interventions

OTHERObservation study without intervention

Observation study without intervention

Sponsors

Shandong Provincial Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \>= 50 years old; 2. Gender: males and females; 3. Provide written informed consent; 4. Satisfactory compliance.

Exclusion criteria

1. Pregnant or lactating women 2. No history of addiction or neurological, psychiatric, or systemic diseases known to affect cognitive function, including head trauma, subdural hematoma, current depression, and epilepsy 3. Any other condition or major systemic diseases that the investigator feels would interfere with trial participation or evaluation of results.

Design outcomes

Primary

MeasureTime frame
number of participants who develop brain aging-related conditions during follow-up5 years

Countries

China

Contacts

Primary ContactLing Gao
gaoling1@medmail.com.cn+8613793187189
Backup ContactJiajun Zhao

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026